|
European Information Network - Ethics in Medicine and BiotechnologyA project of the European Commission,Quality of Life and Management of Living Resources Programme |
Eureth.net Home | News | Events | Literature | Partners | Topics | Links | ENDEBIT | EUROETHICS | Thesaurus |
DRZEs Eurethnet-Home | Contact us |
If you require further information, please contact the organizers directly.
Back to calendar |
|
Date: | 28.01.2004, 10:00-16:30h |
Location: | Amsterdam Hilton, Apollolaan 138, NL 1077 BG Amstedam, The Netherlands Amsterdam The Netherlands |
Keywords: | Pharmaceutics/drugs |
Details: | This workshop will address critical parameters related with the scale-up and the commercial manufacturing of biopharmaceuticals using animal and plants instead of conventional microbial or cell culture bioreactor-based production systems. This workshop will focus on criteria for selection and implementation strategy related to the use of transgenic systems for clinical and for commercial production of biopharmaceuticals. Production system selection and implementation will consider the biochemical properties of the product to be manufactured, its assembly and post-translational modifications, and production volume and cost. In addition the following parameters of transgenic production systems will be discussed: * Agronomic * Economic * Containment * Downstream processability * By-product credit * Geographical location * Capital * Costs * Regulatory * Intellectual property * Ethical and public acceptance The workshop will provide an overview of the diversity of transgenic production systems described in literature (milk, urine, eggs, seeds, foliage) and hosts (cows, goats, chicken, tobacco, corn, alfalfa, barley, rice, brassica) considering how different transgenic systems and hosts have to be matched with product needs. Current state of the industry will also be discussed including status of current products in pre-clinical and clinical development. Participants to this workshop will obtain practical knowledge on alternatives available for biopharmaceutical production based on transgenic systems and the expected performance of the system. As product examples and background on the companies involved in the development of transgenic systems will be discussed, participants should be able to compare their products with those already produced using transgenic technology and who to contact. |
Organizer: | ibc Life Sciences , England |
Contact: | Mrs Laura Beachus Address: The Booking Department, Informa Uk Limited, P.O. Box 406, KT 14 6NN West Byfleet, England Tel: +44 - 20 - 70 17 55 07 Fax: +44 - 20 - 70 17 47 49 Email: cust.serv@informa.com |
Webpage: | http://www.ibc-lifesci.com/scaleup/ |
Eureth.net Home | News | Events | Literature | Partners | Topics | Links | ENDEBIT | EUROETHICS | Thesaurus |
EURETHNET site at © DRZE: last update 21.05.2008 General information | Administration: webmaster@drze.de |